Preventing steroid-induced diabetes with a GLP-1 drug
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether a GLP-1 medication (a type of drug that helps control blood sugar) can prevent diabetes caused by steroid treatments. It is for people who have prediabetes or mild diabetes and are about to receive a short course of steroids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have prediabetes or mild diabetes that is controlled by diet alone (not medication)
- You have not taken any diabetes medication in the last 3 months
- You are not pregnant, planning pregnancy, or breastfeeding
- You do not currently need regular steroid treatment (like prednisone) for a long-term condition
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a GLP-1 receptor agonist (a type of diabetes medication) can safely and effectively treat high blood sugar caused by long-term steroid use. It may help people with type 2 diabetes or steroid-induced diabetes who take oral steroids for conditions like asthma, arthritis, or kidney disease.
This study looks at how to predict and monitor diabetes caused by steroid medications. It may help if you are about to start taking steroids for a medical condition and do not have diabetes.
This study looks at how your genes may change how well a GLP-1–type medicine works to improve prediabetes. It focuses on adults at higher risk of developing diabetes, especially people of Mexican-American background.
This trial studies whether semaglutide can help women with prediabetes after past gestational diabetes return to better blood sugar levels and lower progression to diabetes. It is designed for women who are no longer breastfeeding and can use effective birth control.
This trial tests if the drug semaglutide can prevent the development of diabetes in people who have recently had a kidney transplant. It may help those at higher risk for post-transplant diabetes.
This trial checks whether people who take steroid medicines for more than 3 months are developing early diabetes, using blood tests before and around starting treatment. It may help catch diabetes sooner if it’s starting to develop, even in people who didn’t have diabetes yet.
Hear when a new Steroid-Induced Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.